Prader-Willi Syndrome Market to Exhibit Healthy Growth Rate till 2032, Investigates DelveInsight | Key Companies – Millendo Therapeutics, Levo Therapeutics, Harmony Biosciences, and Soleno Therapeutics

 Breaking News
  • No posts were found

Prader-Willi Syndrome Market to Exhibit Healthy Growth Rate till 2032, Investigates DelveInsight | Key Companies – Millendo Therapeutics, Levo Therapeutics, Harmony Biosciences, and Soleno Therapeutics

April 18
22:09 2022
Prader-Willi Syndrome Market to Exhibit Healthy Growth Rate till 2032, Investigates DelveInsight | Key Companies - Millendo Therapeutics, Levo Therapeutics, Harmony Biosciences, and Soleno Therapeutics
Delveinsight Business Research LLP
DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prader-Willi Syndrome Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Prader-Willi Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Prader-Willi Syndrome Market

Prader-Willi Syndrome: An Overview

According to US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity.

Although considered a “rare” disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.

Prader-Willi Syndrome Market Key Facts

  • As per Foundation for Prader-Willi Syndrome (PWS) Research, the disease occurs in approximately one out of every 15,000 births

  • It affects males and females with equal frequency and affects all races and ethnicities.

  • The estimates place the incidence between 1 in 10,000-30,000 individuals in the general population, while as per “Adult Prader-Willi Syndrome: An Update on Management by Luk Ho-Ming”, the incidence is about 1 in 15,000–25,000 live births. 

  • According to DelveInsight’s estimation, the total prevalent cases of Prader Willi syndrome (PWS) were found to be approx. 47,000 in the 7 Major Markets in the year 2017.

Prader-Willi Syndrome Market

The Prader-Willi Syndrome Market Size is expected to experience a positive shift during the study period owing to the launch of upcoming therapies. The therapies under development are focused on novel approaches that will improve the disease condition.

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Prader-Willi Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Prader-Willi Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Prader-Willi Syndrome Epidemiology

The epidemiology section covers insights into the historical and current Prader-Willi Syndrome patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Prader-Willi Syndrome Epidemiology Subtype Segmentation –

  • Prevalent cases of Prader Willi Syndrome

  • Diagnosed cases of PWS

  • Prader Willi Syndrome (PWS) cases by Mutation types

  • Prader Willi Syndrome (PWS) associated clinical Manifestation

Prader-Willi Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to get launched in the market during the study period. The analysis covers Prader-Willi Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Prader-Willi Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in various stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Prader-Willi Syndrome Therapeutics Analysis

Currently, there is no cure for PWS. The lives of individuals with PWS can be improved with an early diagnosis and careful management of symptoms but more effective therapies are needed. The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. Growth hormone deficiency is present in almost all children and many adults with PWS. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome.

Some of the key companies in the Prader-Willi Syndrome Market include:

  • Millendo Therapeutics

  • Levo Therapeutics

  • Harmony Biosciences 

  • Soleno Therapeutics 

And many more.

Prader-Willi Syndrome Therapies covered in the report include:

  • LV-101

  • Pitolisant

  • Livoletide or AZP-531

  • Diazoxide Controlled Release (DCCR)

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Prader-Willi Syndrome Competitive Intelligence Analysis

4. Prader-Willi Syndrome Market Overview at a Glance

5. Prader-Willi Syndrome Disease Background and Overview

6. Prader-Willi Syndrome Patient Journey

7. Prader-Willi Syndrome Epidemiology and Patient Population

8. Prader-Willi Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Prader-Willi Syndrome Unmet Needs

10. Key Endpoints of Prader-Willi Syndrome Treatment

11. Prader-Willi Syndrome Marketed Products

12. Prader-Willi Syndrome Emerging Therapies

13. Prader-Willi Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Prader-Willi Syndrome Market Outlook (7 major markets)

16. Prader-Willi Syndrome Access and Reimbursement Overview

17. KOL Views on the Prader-Willi Syndrome Market.

18. Prader-Willi Syndrome Market Drivers

19. Prader-Willi Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

Metrorrhagia Market

DelveInsight’s “Metrorrhagia Market” report delivers an in-depth understanding of the historical and forecasted epidemiology, the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States